Phase 1 Malaria,Falciparum Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of LAI MMV055 Alone and in Combination With MMV371 in Healthy Participants
Malaria,Falciparum
Medicines for Malaria Venture72 enrolled1 locationNCT07011511
Recruiting
Phase 1
Safety, Tolerability and Efficacy Against Controlled Human Malaria Infection of PfSPZ-LARC2 Vaccine in Malaria-naïve Adults
Malaria,Falciparum
Sanaria Inc.58 enrolled1 locationNCT06862453
Recruiting
Phase 1
A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants
Malaria,Falciparum
GlaxoSmithKline156 enrolled1 locationNCT06171113
Recruiting
Phase 1
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)
Malaria,Falciparum
University of Oxford56 enrolled1 locationNCT06958198
Recruiting
Phase 1Phase 2
A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.
Malaria,Falciparum
University of Oxford480 enrolled1 locationNCT05790889